Diabetes 51:2405-2411, 2002
© 2002 by the American Diabetes Association, Inc.
Protein Tyrosine Phosphatase 1B Reduction Regulates Adiposity and Expression of Genes Involved in Lipogenesis
Cristina M. Rondinone1,
James M. Trevillyan1,
Jill Clampit1,
Rebecca J. Gum1,
Cathy Berg1,
Paul Kroeger1,
Leigh Frost1,
Bradley A. Zinker1,
Regina Reilly1,
Roger Ulrich1,
Madeline Butler2,
Brett P. Monia2,
Michael R. Jirousek1, and
Jeffrey F. Waring1
1 Metabolic Diseases Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
2 Isis Pharmaceuticals, Carlsbad, California
Protein tyrosine phosphatase 1B (PTP1B) has been implicated as a negative regulator of insulin action. Overexpression of PTP1B protein has been observed in insulin-resistant states associated with obesity. Mice lacking a functional PTP1B gene exhibit increased insulin sensitivity and are resistant to weight gain. To investigate the role of PTP1B in adipose tissue from obese animals, hyperglycemic obese (ob/ob) mice were treated with PTP1B antisense oligonucleotide (ISIS-113715). A significant reduction in adiposity correlated with a decrease of PTP1B protein levels in fat. Antisense treatment also influenced the triglyceride content in adipocytes, correlating with a downregulation of genes encoding proteins involved in lipogenesis, such as sterol regulatory element-binding protein 1 and their downstream targets spot14 and fatty acid synthase, as well as other adipogenic genes, lipoprotein lipase, and peroxisome proliferator-activated receptor . In addition, an increase in insulin receptor substrate-2 protein and a differential regulation of the phosphatidylinositol 3-kinase regulatory subunit (p85 ) isoforms expression were found in fat from antisense-treated animals, although increased insulin sensitivity measured by protein kinase B phosphorylation was not observed. These results demonstrate that PTP1B antisense treatment can modulate fat storage and lipogenesis in adipose tissue and might implicate PTP1B in the enlargement of adipocyte energy stores and development of obesity.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Delibegovic, K. K. Bence, N. Mody, E.-G. Hong, H. J. Ko, J. K. Kim, B. B. Kahn, and B. G. Neel
Improved Glucose Homeostasis in Mice with Muscle-Specific Deletion of Protein-Tyrosine Phosphatase 1B
Mol. Cell. Biol.,
November 1, 2007;
27(21):
7727 - 7734.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Xue, Y.-B. Kim, A. Lee, E. Toschi, S. Bonner-Weir, C. R. Kahn, B. G. Neel, and B. B. Kahn
Protein-tyrosine Phosphatase 1B Deficiency Reduces Insulin Resistance and the Diabetic Phenotype in Mice with Polygenic Insulin Resistance
J. Biol. Chem.,
August 17, 2007;
282(33):
23829 - 23840.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Picha, S. S. Patel, S. Mandiyan, J. Koehn, and L. P. Wennogle
The Role of the C-terminal Domain of Protein Tyrosine Phosphatase-1B in Phosphatase Activity and Substrate Binding
J. Biol. Chem.,
February 2, 2007;
282(5):
2911 - 2917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. F. Pilch and N. Bergenhem
Pharmacological Targeting of Adipocytes/Fat Metabolism for Treatment of Obesity and Diabetes
Mol. Pharmacol.,
September 1, 2006;
70(3):
779 - 785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tups, M. Helwig, S. Stohr, P. Barrett, J. G. Mercer, and M. Klingenspor
Photoperiodic regulation of insulin receptor mRNA and intracellular insulin signaling in the arcuate nucleus of the Siberian hamster, Phodopus sungorus
Am J Physiol Regulatory Integrative Comp Physiol,
September 1, 2006;
291(3):
R643 - R650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Watts, V. P. Manchem, T. A. Leedom, A. L. Rivard, R. A. McKay, D. Bao, T. Neroladakis, B. P. Monia, D. M. Bodenmiller, J. X.-C. Cao, et al.
Reduction of Hepatic and Adipose Tissue Glucocorticoid Receptor Expression With Antisense Oligonucleotides Improves Hyperglycemia and Hyperlipidemia in Diabetic Rodents Without Causing Systemic Glucocorticoid Antagonism
Diabetes,
June 1, 2005;
54(6):
1846 - 1853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. G. Haj, J. M. Zabolotny, Y.-B. Kim, B. B. Kahn, and B. G. Neel
Liver-specific Protein-tyrosine Phosphatase 1B (PTP1B) Re-expression Alters Glucose Homeostasis of PTP1B-/-Mice
J. Biol. Chem.,
April 15, 2005;
280(15):
15038 - 15046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I K Lund, J A Hansen, H S Andersen, N P H Moller, and N Billestrup
Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling
J. Mol. Endocrinol.,
April 1, 2005;
34(2):
339 - 351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Galic, C. Hauser, B. B. Kahn, F. G. Haj, B. G. Neel, N. K. Tonks, and T. Tiganis
Coordinated Regulation of Insulin Signaling by the Protein Tyrosine Phosphatases PTP1B and TCPTP
Mol. Cell. Biol.,
January 15, 2005;
25(2):
819 - 829.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wassef, L. Bernier, J. Davignon, and J. S. Cohn
Synthesis and Secretion of ApoC-I and ApoE during Maturation of Human SW872 Liposarcoma Cells
J. Nutr.,
November 1, 2004;
134(11):
2935 - 2941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Zabolotny, F. G. Haj, Y.-B. Kim, H.-J. Kim, G. I. Shulman, J. K. Kim, B. G. Neel, and B. B. Kahn
Transgenic Overexpression of Protein-tyrosine Phosphatase 1B in Muscle Causes Insulin Resistance, but Overexpression with Leukocyte Antigen-related Phosphatase Does Not Additively Impair Insulin Action
J. Biol. Chem.,
June 4, 2004;
279(23):
24844 - 24851.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Kushner, F. G. Haj, L. D. Klaman, M. A. Dow, B. B. Kahn, B. G. Neel, and M. F. White
Islet-Sparing Effects of Protein Tyrosine Phosphatase-1b Deficiency Delays Onset of Diabetes in IRS2 Knockout Mice
Diabetes,
January 1, 2004;
53(1):
61 - 66.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Pasquali, M.-L. Curchod, S. Walchli, X. Espanel, M. Guerrier, F. Arigoni, G. Strous, and R. H. van Huijsduijnen
Identification of Protein Tyrosine Phosphatases with Specificity for the Ligand-Activated Growth Hormone Receptor
Mol. Endocrinol.,
November 1, 2003;
17(11):
2228 - 2239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Shimizu, S. Ugi, H. Maegawa, K. Egawa, Y. Nishio, T. Yoshizaki, K. Shi, Y. Nagai, K. Morino, K.-i. Nemoto, et al.
Protein-tyrosine Phosphatase 1B as New Activator for Hepatic Lipogenesis via Sterol Regulatory Element-binding Protein-1 Gene Expression
J. Biol. Chem.,
October 31, 2003;
278(44):
43095 - 43101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsuki, R. Horai, K. Sudo, and Y. Iwakura
IL-1 Plays an Important Role in Lipid Metabolism by Regulating Insulin Levels under Physiological Conditions
J. Exp. Med.,
September 15, 2003;
198(6):
877 - 888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Gum, L. L. Gaede, M. A. Heindel, J. F. Waring, J. M. Trevillyan, B. A. Zinker, M. E. Stark, D. Wilcox, M. R. Jirousek, C. M. Rondinone, et al.
Antisense Protein Tyrosine Phosphatase 1B Reverses Activation of p38 Mitogen-Activated Protein Kinase in Liver of ob/ob Mice
Mol. Endocrinol.,
June 1, 2003;
17(6):
1131 - 1143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Asante-Appiah and B. P. Kennedy
Protein tyrosine phosphatases: the quest for negative regulators of insulin action
Am J Physiol Endocrinol Metab,
April 1, 2003;
284(4):
E663 - E670.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Gum, L. L. Gaede, S. L. Koterski, M. Heindel, J. E. Clampit, B. A. Zinker, J. M. Trevillyan, R. G. Ulrich, M. R. Jirousek, and C. M. Rondinone
Reduction of Protein Tyrosine Phosphatase 1B Increases Insulin-Dependent Signaling in ob/ob Mice
Diabetes,
January 1, 2003;
52(1):
21 - 28.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|